Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia?

Area of Science:

• Neuroscience
• Immunology
• Neurology

Background:

• Post-stroke cognitive decline and dementia affect 30% of survivors, with unclear causes.
• B-lymphocytes and antibodies are found in human and mouse brains after stroke.
• B-cell ablation prevents cognitive impairment in mouse stroke models.

Purpose of the Study:

• To review the role of B-lymphocytes in the development of post-stroke dementia.
• To explore the dual role of B-lymphocytes in stroke recovery versus pathogenicity.

Main Methods:

• Review of existing literature on B-cell responses in stroke models and human subjects.
• Analysis of studies investigating B-cell ablation and regulatory B-cell function post-stroke.

Main Results:

• Evidence suggests B-cells can be pathogenic, contributing to cognitive decline after stroke.
• Regulatory B-cells may play a beneficial role in stroke recovery.
• The balance between beneficial and detrimental B-cell effects appears variable.

Conclusions:

• B-lymphocytes are implicated in post-stroke dementia, representing a potential therapeutic target.
• Understanding the heterogeneity of B-cell responses is crucial for effective treatment strategies.
• Further research is needed to elucidate the precise mechanisms and therapeutic potential of targeting B-cells in stroke survivors.